SEARCH NEWS & VIEWS


Healthy red blood cells owe their shape to muscle-like structures
Non-psychoactive cannabis ingredient could help addicts stay clean
Cancer researchers receive more than $2 million to eradicate common form of leukemia
Scripps Research discovery paves way for better flu prevention, treatment

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
Healthy red blood cells owe their shape to muscle-like structures

Discovery by Scripps Research scientists may offer insight into treating blood disorders such as sickle cell anemia.

Non-psychoactive cannabis ingredient could help addicts stay clean

The Weiss lab sheds light on the use of Cannabidiol to reduce drug relapse risk

Cancer researchers receive more than $2 million to eradicate common form of leukemia

The Rader lab is working to develop new treatments for chronic lymphocytic leukemia.

Scripps Research discovery paves way for better flu prevention, treatment

Antibodies in the lungs attack the flu in two different ways.

  • Families facing rare neurological disease drive groundbreaking research
  • Graduate program at The Scripps Research Institute earns another top ten ranking
  • Researchers uncover culprit in Parkinson's brain cell die-off
  • A new cross-coupling simplifies the synthesis of drug-like molecules
  • Cross-bred flies reveal new clues about how proteins are regulated
  • Decoding the genome’s dark matter
  • TSRI receives $10 million grant to study effects of alcohol on the brain
  • Video: TSRI researchers bring scattered data together
  • TSRI researchers identify gene responsible for mesenchymal stem cells’ stem-ness
  • Scripps Translational Science Institute, Nature Research launch open-access digital medicine journal
  • Scientists discover workings of first promising Marburg virus treatment
  • Novel regenerative drug for osteoarthritis entering clinical trials
  • Dysfunctional gene may be culprit in some Crohn’s disease cases
  • Scientists discover possible master switch for programming cancer immunotherapy